Aisling Capital IV, LP

Insider Reports History

Entity
Company
Location
888 Seventh Avenue, 12 Th Floor, New York, NY
Signature
AISLING CAPITAL IV, LP, by Aisling Capital Partners IV, LP, its General Partner, by Aisling Capital Partners IV LLC, its General Partner, /s/ Andrew Schiff, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aisling Capital IV, LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Elevation Oncology, Inc. 10%+ Owner Stock Option (Right to Buy) 31.2K Jun 16, 2023 Indirect

Insider Reports Filed by Aisling Capital IV, LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELEV Elevation Oncology, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 29, 2021 5 $3M 4 Jul 1, 2021 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner